Private equity firm acquires Cambridge Major for $212 million

American Capital (Bethesda, MD) has reached a deal to acquire Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), for $212 million. CML was a portfolio company of private equity firm Arlington Capital Partners (Washington). CML expands American Capital’s portfolio of health-care products and services companies, which have aggregate revenues of over $600 million. “The management team at CML chose to partner with American Capital based on the depth of financial...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers